跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LUCRIN DEPOT 4-MONTH Leuprorelin acetate 30mg powder for injection prefilled dual-chamber syringe with 23 G needle - TGA Drug Approval Details
Approvals
/
TGA
/
LUCRIN DEPOT 4-MONTH Leuprorelin acetate 30mg powder for injection prefilled dual-chamber syringe with 23 G needle
Approved
STANDARD
LUCRIN DEPOT 4-MONTH Leuprorelin acetate 30mg powder for injection prefilled dual-chamber syringe with 23 G needle
AbbVie Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
ef97bd6a2f1eee75
Company
AbbVie Pty Ltd
Type
Standard
Approval Details
Approval Id
ef97bd6a2f1eee75
Product Name
LUCRIN DEPOT 4-MONTH Leuprorelin acetate 30mg powder for injection prefilled dual-chamber syringe with 23 G needle
Artg Id
114304
Artg Name
LUCRIN DEPOT 4-MONTH leuprorelin acetate 30mg powder for injection prefilled dual-chamber syringe
Sponsor
AbbVie Pty Ltd
Company Detail Path
/organization/abbvie-pty-ltd
Artg Date
2005-04-08
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/47044a1de38a3dd13364c28407808903.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/3766ff8e54dfddcfe5ce365786759c31.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
ef97bd6a2f1eee75
Type
Standard
Back to TGA Approvals